Obagi Medical (OMPI) Bidding War Could Take Stock as High as $27/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. WYFI
6. BTGO
7. NVDA
8. STUB
9. EAT
10. ARX

Go back to Obagi Medical (OMPI) Bidding War Could Take Stock as High as $27/Share

Valeant (VRX) May Tuck Tail if Obagi (OMPI) Bidding War Heats Up - Analyst

April 4, 2013 1:33 PM EDT

Yesterday Valeant Pharmaceuticals (NYSE: VRX) raised its offer for Obagi Medical Products, Inc. (NASDAQ: OMPI) from $19.75 to $24 per share, topping Merz's $22 per share bid. Commenting on the development, analyst David M Steinberg of Deutsche bank said he... More

Obagi Medical (OMPI) Acknowledges Merz Pharma Offer, Will Review

April 2, 2013 12:31 PM EDT

On April 2, 2012, Obagi Medical Products, Inc. (Nasdaq: OMPI) announced that the Obagi Board of Directors had received an unsolicited letter from Merz Pharma offering $22 per share cash to acquire the Company, and the Obagi Board of Directors will evaluate Merz Pharmas offer and... More

Merz Pharma Tops Valeant (VRX) Offer for Obagi Medical Products (OMPI), Offers $22/Share

April 2, 2013 7:51 AM EDT

In a letter to the Board of Directors of Obagi Medical Products, Inc. (NASDAQ: OMPI) Merz Pharma Group today outlined a proposal to acquire all of the outstanding common stock of Obagi for $22 per share in cash. This proposal represents a 58% premium to Obagi's closing share price on Thursday, March 14, 2013, the last trading day prior to the disclosure on Obagi's fourth quarter earnings call that Obagi had engaged a financial advisor to help explore "all opportunities."

On March 20, 2013, Obagi announced that it entered into a definitive merger agreement with Valeant Pharmaceuticals... More